Price to Earnings (P/E)
since 2005
Calculation
Vertex Pharmaceuticals Inc., P/E, long-term trends, calculation
| P/E | = | Share price1, 2, 3 | ÷ | Earnings per share1 (EPS) | EPS1 | = | Net income (loss)1 (in thousands) |
÷ | No. shares of common stock outstanding2 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 15, 2024 | 30.42 | = | 426.29 | ÷ | 14.01 | 14.01 | = | 3,619,600 | ÷ | 258,307,816 | |
| Feb 10, 2023 | 23.02 | = | 297.40 | ÷ | 12.92 | 12.92 | = | 3,322,000 | ÷ | 257,091,441 | |
| Feb 9, 2022 | 26.55 | = | 244.24 | ÷ | 9.20 | 9.20 | = | 2,342,100 | ÷ | 254,576,691 | |
| Feb 11, 2021 | 20.18 | = | 210.50 | ÷ | 10.43 | 10.43 | = | 2,711,647 | ÷ | 259,960,062 | |
| Feb 13, 2020 | 52.90 | = | 240.09 | ÷ | 4.54 | 4.54 | = | 1,176,810 | ÷ | 259,268,593 | |
| Feb 13, 2019 | 22.59 | = | 185.25 | ÷ | 8.20 | 8.20 | = | 2,096,896 | ÷ | 255,656,889 | |
| Feb 15, 2018 | 155.08 | = | 160.94 | ÷ | 1.04 | 1.04 | = | 263,484 | ÷ | 253,891,984 | |
| Feb 23, 2017 | — | = | 85.73 | ÷ | -0.45 | -0.45 | = | -112,052 | ÷ | 248,438,127 | |
| Feb 16, 2016 | — | = | 85.37 | ÷ | -2.26 | -2.26 | = | -556,334 | ÷ | 246,391,955 | |
| Feb 13, 2015 | — | = | 113.66 | ÷ | -3.05 | -3.05 | = | -738,555 | ÷ | 242,088,884 | |
| Feb 11, 2014 | — | = | 84.98 | ÷ | -1.89 | -1.89 | = | -445,028 | ÷ | 235,771,942 | |
| Mar 1, 2013 | — | = | 46.17 | ÷ | -0.49 | -0.49 | = | -107,032 | ÷ | 218,188,628 | |
| Feb 22, 2012 | 267.42 | = | 37.60 | ÷ | 0.14 | 0.14 | = | 29,574 | ÷ | 210,335,993 | |
| Feb 17, 2011 | — | = | 39.85 | ÷ | -3.69 | -3.69 | = | -754,626 | ÷ | 204,412,712 | |
| Feb 19, 2010 | — | = | 40.70 | ÷ | -3.20 | -3.20 | = | -642,178 | ÷ | 200,576,408 | |
| Feb 17, 2009 | — | = | 33.10 | ÷ | -3.02 | -3.02 | = | -459,851 | ÷ | 152,189,782 | |
| Feb 11, 2008 | — | = | 18.21 | ÷ | -2.94 | -2.94 | = | -391,279 | ÷ | 132,964,533 | |
| Mar 1, 2007 | — | = | 30.03 | ÷ | -1.63 | -1.63 | = | -206,891 | ÷ | 126,650,456 | |
| Mar 16, 2006 | — | = | 39.49 | ÷ | -1.85 | -1.85 | = | -203,417 | ÷ | 109,734,852 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1 US$
2 Data adjusted for splits and stock dividends.
3 Closing price as at the filing date of Vertex Pharmaceuticals Inc. Annual Report.
Comparison to Competitors
Vertex Pharmaceuticals Inc., P/E, long-term trends, comparison to competitors
| Vertex Pharmaceuticals Inc. | AbbVie Inc. | Amgen Inc. | Bristol-Myers Squibb Co. | Danaher Corp. | Eli Lilly & Co. | Gilead Sciences Inc. | Johnson & Johnson | Merck & Co. Inc. | Moderna Inc. | Pfizer Inc. | Regeneron Pharmaceuticals Inc. | Thermo Fisher Scientific Inc. | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 15, 2024 | 30.42 | 63.84 | 23.14 | 12.27 | 39.09 | 135.24 | 16.17 | 10.73 | 893.99 | — | 73.42 | 25.99 | 35.65 |
| Feb 10, 2023 | 23.02 | 22.62 | 19.56 | 23.97 | 25.65 | 50.08 | 22.68 | 22.97 | 19.21 | 6.43 | 7.58 | 19.68 | 30.55 |
| Feb 9, 2022 | 26.55 | 22.07 | 21.05 | 20.92 | 29.94 | 40.66 | 12.36 | 20.93 | 14.78 | 5.00 | 11.76 | 8.37 | 27.35 |
| Feb 11, 2021 | 20.18 | 40.17 | 18.82 | — | 44.49 | 31.95 | 641.48 | 28.92 | 26.72 | — | 19.62 | 15.09 | 27.89 |
| Feb 13, 2020 | 52.90 | 17.82 | 17.07 | 41.99 | 38.34 | 16.19 | 16.45 | 25.99 | 20.60 | — | 11.63 | 19.86 | 33.36 |
| Feb 13, 2019 | 22.59 | 20.60 | 14.01 | 16.81 | 29.77 | 39.13 | 15.26 | 23.74 | 33.46 | — | 21.58 | 18.17 | 35.19 |
| Feb 15, 2018 | 155.08 | 35.47 | 64.06 | 103.55 | 27.25 | — | 22.75 | 268.10 | 61.63 | — | 9.99 | 28.99 | 37.66 |
| Feb 23, 2017 | — | 16.54 | 16.03 | 20.56 | 23.02 | 32.39 | 6.83 | 20.08 | 46.14 | — | 28.10 | 42.64 | 30.45 |
| Feb 16, 2016 | — | 17.01 | 15.95 | 64.22 | 17.85 | 33.35 | 6.75 | 18.80 | 31.64 | — | 26.37 | 60.50 | 26.19 |
| Feb 13, 2015 | — | 55.08 | 22.96 | 49.80 | 23.69 | 33.06 | 12.85 | 17.15 | 13.94 | — | 23.03 | 118.44 | 27.26 |
| Feb 11, 2014 | — | 19.64 | 18.69 | 35.01 | 19.74 | 13.88 | 42.00 | 18.72 | 37.83 | — | 9.32 | 77.00 | 38.43 |
| Mar 1, 2013 | — | 11.51 | 15.68 | 30.56 | 17.73 | 14.99 | 25.20 | 19.64 | 20.94 | — | 13.51 | 21.42 | 22.54 |
| Feb 22, 2012 | 267.42 | — | 14.61 | 15.07 | 16.92 | 10.42 | 12.20 | 18.48 | 18.63 | — | 15.99 | — | 15.58 |
| Feb 17, 2011 | — | — | 10.53 | 13.99 | 18.29 | 7.86 | 10.68 | 12.23 | 116.63 | — | 18.63 | — | 20.87 |
| Feb 19, 2010 | — | — | 12.10 | 4.03 | 20.93 | 9.18 | 16.29 | 14.22 | 9.00 | — | 16.41 | — | 23.49 |
| Feb 17, 2009 | — | — | 12.06 | 7.68 | 12.56 | — | 20.29 | 11.67 | 6.53 | — | 10.25 | — | 15.25 |
| Feb 11, 2008 | — | — | 15.64 | 20.60 | 17.35 | 19.26 | 25.19 | 17.07 | 29.88 | — | 18.51 | — | 30.76 |
| Mar 1, 2007 | — | — | 25.43 | 34.64 | 19.65 | 22.40 | — | 17.02 | 21.57 | — | 9.18 | — | 113.28 |
| Mar 16, 2006 | — | — | 23.70 | 14.96 | 21.38 | 31.90 | 34.15 | 16.95 | 16.62 | — | 23.92 | — | 25.36 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Sector (Pharmaceuticals, Biotechnology & Life Sciences)
Vertex Pharmaceuticals Inc., P/E, long-term trends, comparison to sector (pharmaceuticals, biotechnology & life sciences)
| Vertex Pharmaceuticals Inc. | Pharmaceuticals, Biotechnology & Life Sciences | |
|---|---|---|
| Feb 15, 2024 | 30.42 | 35.36 |
| Feb 10, 2023 | 23.02 | 19.24 |
| Feb 9, 2022 | 26.55 | 17.76 |
| Feb 11, 2021 | 20.18 | 37.29 |
| Feb 13, 2020 | 52.90 | 20.82 |
| Feb 13, 2019 | 22.59 | 23.13 |
| Feb 15, 2018 | 155.08 | 34.49 |
| Feb 23, 2017 | — | 20.28 |
| Feb 16, 2016 | — | 18.89 |
| Feb 13, 2015 | — | 20.74 |
| Feb 11, 2014 | — | 19.10 |
| Mar 1, 2013 | — | 17.34 |
| Feb 22, 2012 | 267.42 | 16.25 |
| Feb 17, 2011 | — | 15.61 |
| Feb 19, 2010 | — | 11.39 |
| Feb 17, 2009 | — | 11.95 |
| Feb 11, 2008 | — | 19.74 |
| Mar 1, 2007 | — | 17.28 |
| Mar 16, 2006 | — | 20.69 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Industry (Health Care)
Vertex Pharmaceuticals Inc., P/E, long-term trends, comparison to industry (health care)
| Vertex Pharmaceuticals Inc. | Health Care | |
|---|---|---|
| Feb 15, 2024 | 30.42 | 30.09 |
| Feb 10, 2023 | 23.02 | 314,676.00 |
| Feb 9, 2022 | 26.55 | 19.87 |
| Feb 11, 2021 | 20.18 | 29.50 |
| Feb 13, 2020 | 52.90 | 21.10 |
| Feb 13, 2019 | 22.59 | 25.51 |
| Feb 15, 2018 | 155.08 | 29.68 |
| Feb 23, 2017 | — | 21.38 |
| Feb 16, 2016 | — | 19.10 |
| Feb 13, 2015 | — | 20.89 |
| Feb 11, 2014 | — | 18.14 |
| Mar 1, 2013 | — | 15.43 |
| Feb 22, 2012 | 267.42 | 15.48 |
| Feb 17, 2011 | — | 14.45 |
| Feb 19, 2010 | — | 11.43 |
| Feb 17, 2009 | — | 12.78 |
| Feb 11, 2008 | — | 18.99 |
| Mar 1, 2007 | — | 18.38 |
| Mar 16, 2006 | — | 21.11 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).